Clinical Data this week announced that triple-digit growth in its pharmacogenomics unit contributed to a 39-percent increase in first-quarter revenues.
The news comes one week after the company announced it had acquired Adenosine Therapeutics for up to $60 million in an effort to expand its pipeline of potential therapeutic/diagnostic combination products.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
